Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.
Publication
, Journal Article
Browning, DJ; Yokogawa, N; Greenberg, PB; Perlman, E
Published in: Am J Ophthalmol
February 2021
Duke Scholars
Published In
Am J Ophthalmol
DOI
EISSN
1879-1891
Publication Date
February 2021
Volume
222
Start / End Page
400 / 401
Location
United States
Related Subject Headings
- Retinal Diseases
- Ophthalmology & Optometry
- Mass Screening
- Hydroxychloroquine
- Humans
- Antirheumatic Agents
- 3212 Ophthalmology and optometry
- 1117 Public Health and Health Services
- 1113 Opthalmology and Optometry
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Browning, D. J., Yokogawa, N., Greenberg, P. B., & Perlman, E. (2021). Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines. Am J Ophthalmol, 222, 400–401. https://doi.org/10.1016/j.ajo.2020.09.015
Browning, David J., Naoto Yokogawa, Paul B. Greenberg, and Elliot Perlman. “Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.” Am J Ophthalmol 222 (February 2021): 400–401. https://doi.org/10.1016/j.ajo.2020.09.015.
Browning DJ, Yokogawa N, Greenberg PB, Perlman E. Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines. Am J Ophthalmol. 2021 Feb;222:400–1.
Browning, David J., et al. “Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.” Am J Ophthalmol, vol. 222, Feb. 2021, pp. 400–01. Pubmed, doi:10.1016/j.ajo.2020.09.015.
Browning DJ, Yokogawa N, Greenberg PB, Perlman E. Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines. Am J Ophthalmol. 2021 Feb;222:400–401.
Published In
Am J Ophthalmol
DOI
EISSN
1879-1891
Publication Date
February 2021
Volume
222
Start / End Page
400 / 401
Location
United States
Related Subject Headings
- Retinal Diseases
- Ophthalmology & Optometry
- Mass Screening
- Hydroxychloroquine
- Humans
- Antirheumatic Agents
- 3212 Ophthalmology and optometry
- 1117 Public Health and Health Services
- 1113 Opthalmology and Optometry
- 1103 Clinical Sciences